USFDA News

Companies

USFDA pulls up Aspen Biopharma Labs for manufacturing lapses at API plant

USFDA pulls up Aspen Biopharma Labs for manufacturing lapses at API plant

1 min read16 Apr 2025
Global

Will DOGE Take a Bite Out of This Spy Firm’s Stock? That’s Classified

The secretive nature of Booz Allen’s government work makes it nearly impossible for investors to gauge how federal cutbacks will affect the business.

2 min read16 Apr 2025
From:
Companies

How Wockhardt is packing for the road less travelled

Wockhardt will deepen its novel antibiotics pipeline over the next five years and focus on building a biosimilar business for weight loss and anti-diabetic medicine, as it pivots away from the US generics market.

7 min read3 Apr 2025
Money

Mint Horizons, a masterclass series on global investing launches in Bengaluru

Mint Horizons is a masterclass series aimed at Indian investors seeking to navigate global markets amid local volatility. Featuring top experts, the workshops will take place in Bengaluru, Mumbai, Delhi and more cities.

3 min read18 Mar 2025
Companies

USFDA pulls up Granules India for lapses in maintaining storage facilities, equipment at Telangana plant

USFDA pulls up Granules India for lapses in maintaining storage facilities, equipment at Telangana plant

2 min read9 Mar 2025
Markets

Will Donald Trump turn out to be a bitter pill for Indian pharma stocks again?

The US healthcare system under Trump 2.0 are likely to benefit Indian players, except for the push for increased US drug production. It said that expanding US drug manufacturing on a large scale is a counter-intuitive move, as it would likely lead to higher drug prices.

4 min read23 Jan 2025
Markets

Granules India shares plunge 16% after USFDA inspection ends with 6 observations

Granules India shares fell over 16% on September 12 after the USFDA inspection revealed six observations. The company reassured investors of its commitment to address the issues and uphold quality standards while promising timely updates.

1 min read12 Sep 2024
Markets

US FDA hands a chill pill to Lupin

Faster approval of products are crucial for Lupin, which has been under pressure in its US business

2 min read17 Dec 2021
News

Zydus Cadila gets tentative nod from USFDA to market diabetes drug

Linagliptin tablets are used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes Shares of Cadila Healthcare were trading 0.88% lower at ₹414.75 apiece on BSE

1 min read29 Oct 2020
Companies

Zydus Cadila gets USFDA nod for muscle relaxant injection

Cadila Healthcare says Zydus Cadila has received final approval from the USFDA to market Cisatracurium Besylate Injection USP in the strength of 20 mg (base)/10 mL (2 mg/mL) multiple-dose vial

1 min read2 Sep 2020

Popular Topics

Budget

The Union Budget contains details about the estimated receipts and the expenditure of the government for a particular fiscal year. The Budget is allotted for the upcoming fiscal year, which runs from 1st April to 31st March of the next year. Here is a quick guide on how the Union Budget is prepared

25 Articles